951 days since the first case of coronavirus in the UK.

The ZOE COVID Study’s positive symptomatic case estimate is currently 114,914 cases (+11.7% in a week). The 7-day estimate shows 762,794 cases (+3.6%). On average, it is now estimated that at least 108,971 people* are still infected by coronavirus every day in the UK.

(*this is the equivalent of the population ¹ of Rugby ² in Warwickshire being infected every day.)


Vaccination remains the best defence against severe disease and hospitalisation. It is also very much sensible to wear a face covering in crowded, enclosed spaces.



🙈🙉🙊 #CovidIsNotOver


First published in September 2022.







covid summary


Latest UK Dashboard


Our reporting strategy

Since 27 July we don’t publish the UKHSA data in our daily reporting. Those figures are just conveniently and undoubtedly flawed. Instead, we now focus on the ZOE COVID Study and the ONS Infection Survey data.

Our readers deserve the truth about COVID-19 and the UK government has clearly been doing everything – from ending free tests to irregular dashboard reports, delaying and ending some data reports – to make sure the media slowly lose interest in COVID reporting and get the public to believe both that they can live with the virus and that the pandemic is over. This is wrong and untrue, as the WHO and most public health experts have repeatedly told us.

For these reasons, PMP Magazine has so far, and will continue to publish COVID daily updates because we see it as part of our mission to always report the truth, even if it means we are the last media in the UK to do so.

While others are sleepwalking to hide the inconvenient truth about COVID-19, PMP Magazine isn’t giving up! Our daily report is free and accessible to all.

Please support our work with a donation: PMP-Magazine.com/crowdfunding

COVID is not over.

Reminder on data reporting in the UK

Since 1 July 2022, the COVID-19 UKHSA Dashboard has moved to weekly reporting. From 8 September 2022, updates take place on Thursdays.
The reporting of ZOE COVID Study data has remained daily.
The reporting of ONS Infection Survey data has remained weekly with a 7-day lag.




(Source: UKHSA | ZOE | ONS)


Zoe COVID Study Estimates

■ Daily Estimated Cases

After having plateaued for a couple of weeks, we seem to have reached an inflection point this week as the number of symptomatic infections has started to increase again. How prepared are we for the inevitable autumn and winter waves?







ONS Infection Survey Estimates

■ Weekly Estimates Cases

The percentage of people testing positive for coronavirus continued to decrease in England, Wales and Scotland in the latest week (ending 23 August 2022). The trend was uncertain in Northern Ireland.



■ Weekly COVID-19 Recorded Deaths

Deaths involving COVID-19 increased in the UK
According to the ONS, the number of deaths registered in the UK involving COVID-19 was 505 in the week ending 26 August 2022, down from 622 in the previous week. The total number of UK deaths was 12,330, which was 15.4% above the five-year average (1,646 excess deaths). This means COVID-19 deaths accounted for 4.1% of all deaths in the latest week, a decrease from 5.0% in the previous week.







latest guidance


UK Government’s List of symptoms of COVID-19

After two years without updating its list of just three symptoms of COVID-19 (a high temperature, a new continuous cough and a loss or change to the sense of smell or taste), the NHS has finally updated its list of symptoms of COVID:

😩 Shortness of breath
🥱 Feeling tired or exhausted
🤕 An aching body
🤯 A headache
🤐 A sore throat
🤧 A blocked or runny nose
😞 Loss of appetite
🥴 Diarrhoea
🤮 Feeling sick or being sick

No change to MHRA advice on the safety and effectiveness of COVID-19 vaccines for those who are pregnant or breastfeeding

Our advice remains that the COVID-19 vaccines are safe and effective during pregnancy and breastfeeding.

We are aware of false claims on social media that our advice on the safety and effectiveness of COVID-19 vaccines while pregnant or breastfeeding has changed.

We would like to reassure the public that our advice has not changed. Our advice remains that the COVID-19 vaccines are safe and effective during pregnancy and breastfeeding and there is substantial evidence to support this advice.

(Source: MHRA, Medicines and Healthcare products Regulatory Agency)

TRAVEL: Entry rules and restrictions

Check out the latest situation for 20 of the top travel destinations for Brits:



ZOE COVID Study’s Top 20 symptoms of COVID-19 (as of 25-Aug-2022)






latest news


Social distancing and face mask use has fallen since spring 2022 — ONS

The proportion of people taking preventative measures or feeling worried about COVID-19 has generally decreased since spring 2022.

Around one in four (26%) people said that they always or often maintained social distancing between 17 to 29 August 2022, a decrease from almost 4 in 10 (38%) in the spring (13 to 24 April 2022). There was also a drop in the proportion of people wearing face coverings, from 65% in the spring to 30% in the latest period.

Over 4 in 10 (43%) of adults aged 70 years and over said they maintained social distancing, compared with around 1 in 10 (10%) adults aged 16 to 29 years. Around 6 in 10 (61%) of adults aged 70 years and over were very or somewhat worried about new COVID-19 variants, compared with around 3 in 10 (30%) adults aged 16 to 29 years.

(Source: ONS)

JCVI advises use of additional bivalent vaccine for autumn booster campaign — UKHSA

Following on from the previous advice on which vaccines should be used in this year’s autumn booster programme, the Joint Committee on Vaccination and Immunisation (JCVI) has updated its published advice to include an additional bivalent vaccine now approved by the Medicines and Healthcare products Regulatory Agency (MHRA).

Studies indicate the Pfizer-BioNTech bivalent vaccine produces a marginally higher immune response against some variants than the Pfizer-BioNTech mRNA Original ‘wild-type’ vaccine. The clinical relevance of these small differences is uncertain

‘Bivalent’ vaccines have been developed by global manufacturers since the emergence and dominance of the Omicron variant. These vaccines are targeted against antigens (substances that induce an immune response) from 2 different COVID-19 strains, or variants.

All of the available booster vaccines offer very good protection against severe illness from COVID-19. As more vaccines continue to be developed, the committee will consider their use in the autumn programme.

Professor Wei Shen Lim, Chair of COVID-19 immunisation on the JCVI, said:

“It is very encouraging that more vaccines continue to become available and we now have another option to add to the vaccines already advised for the autumn booster campaign.

“Winter is typically the time of greatest threat from respiratory infections. We strongly encourage everyone who is eligible to have their booster vaccine this autumn when it is offered. This is our best defence against becoming severely ill from COVID-19.”

(Source: UKHSA)



For more stories like this,
sign up to our FREE Briefings today.






covid tweets







we need your help


Since February 2022, the UKHSA has slowly reduced the publishing of its daily COVID updates, following the UK Government’s narrative that we should all “live with the virus”. UKHSA now reports only once a week.

The virus doesn’t take a break 6 days a week.
It doesn’t infect people from time to time.
It doesn’t stop at a border either.

The virus still spreads and kills people every day in the UK and around the world. COVID-19 is NOT over.

We, at PMP, have decided to continue to publish the latest COVID data available every day, especially the Zoe COVID Study estimates – probably more accurate than the UK Government’s own data since free testing has ended in England,  and the ONS COVID Infection Survey estimates.

Please, support our work through our crowdfunding to help us to continue our COVID reporting: Donate now.


🙈🙉🙊 #CovidIsNotOver.






must-read


What scientists have learnt from COVID lockdowns
Restrictions on social contact stemmed disease spread, but weighing up the ultimate costs and benefits of lockdown measures is a challenge.
Study finds link between poor mental health and long Covid
High levels of distress before coronavirus infection raises risk of long Covid, say Harvard researchers
Ministers cut NHS Covid jabs ad budget by 63% despite winter wave fears
Exclusive: Government accused of complacency as funding to promote Covid and flu vaccines reduced to £4m
Should You Mix and Match Omicron Boosters? Here’s What to Know
There are no human data yet on the new Omicron booster, but past research hints at an answer
Doctors are taking it on themselves to figure out long Covid
Absent more guidance from the government, physicians are sharing ideas for treating the mysterious condition.
10.5 million children were orphaned or lost a primary caregiver due to COVID, study finds
A study published Tuesday estimates that 10.5 million children worldwide lost a primary caregiver or were orphaned due to COVID-19.
It’s reassuring that summer was spent wisely planning for the coming COVID winter... or was it?
This summer, the government has done absolutely nothing to prepare schools, the NHS and communities for the coming autumn COVID wave nor has it got any plans for the subsequent winter COVID wave, a health expert explains.






variant news



■ 🧬 COG-UK sequencing





(Source: COG-UK)








vaccination


💉 Latest UK Vaccination

Note: UK vaccination data is now published weekly on Wednesdays.






(Source: UK Health Security Agency + Public Health Wales
+ Public Health Scotland + HSC NI + ONS)


Note: Data cross-referenced with the latest official data from the UK dashboard.

PMP Xtra

Total UK population: 67,081,234 (last year: 66,796,800), via ONS (subject to changes in population over the year). These figures were updated on 25 June 2021. (Source: ONS)









long covid


🧩 Long COVID


LONG COVID UK ESTIMATE (ONS – 1-Sep-2022, Data up to 31-Jul-2022)

🚨 2 million people currently live with long COVID in the UK (vs 1.8 million last month)
🚨 3.1% of the UK population currently live with long COVID (vs 2.8%)
🚨 1 in 33 people in the UK has long COVID
🚨 Long COVID symptoms still adversely affect the day-to-day activities of 1.5 million people, 73% of long COVID sufferers (vs 1.3 million)
🚨 Of those, 384,000 people (19%) are “limited a lot” (vs 369,000)
🚨 582,000 (29%) first had COVID-19 before Alpha became the main variant; 256,000 (13%) in the Alpha period, 386,000 (19%) in the Delta period, and 681,000 (34%) in the Omicron period.
LONG COVID UK ESTIMATE

🚨 Most common symptoms of long COVID
▫ fatigue (62%) ▲
▫ shortness of breath (37%) ▲
▫ difficulty concentrating (33%) ▲
▫ muscle ache (31%) ▲

🚨 Prevalence of long COVID is greatest in people
▫ aged 35-69 years
▫ females
▫ living in more deprived areas
▫ working in social care
▫ with another activity limiting health condition or disability

🚨 Long COVID by occupation (ONS – 29 Jun-2022)
▫ Police and protective services (25%)
▫ Education (22%)
▫ Social care sector (22%)


Note: There has been a change in the way the data are collected by the ONS. As a result, these estimates are not fully comparable with those in previous bulletins. For more details on these changes, please see the Impact of moving to remote data collection.








long covid kids


🧩 Long COVID Kids

LONG COVID KIDS

According to a recent systematic review and meta-analyses of Long-COVID in children and adolescents published in Nature:

🚨 Long COVID affects 1 in 4 infected children (25.24%)

🚨 For hospitalised children, prevalence of long-COVID is nearly 1 in 3 infected children (29.19%)

🚨 Most prevalent clinical manifestations of Long COVID in children/adolescents:
▫ mood symptoms (16.50%)
▫ fatigue (9.66%)
▫ sleep disorders (8.42%)
▫ headache (7.84%)
▫ respiratory symptoms (7.62%)
▫ sputum production or nasal congestion (7.53%)
▫ cognitive symptoms (6.27%)
▫ loss of appetite (6.07%)
▫ exercise intolerance (5.73%)
▫ altered smell (5.60%)

🚨 Children infected by COVID-19 have a higher risk of persistent dyspnea, anosmia/ageusia, and/or fever

🚨 Like adults, the pediatric population’s risk factors associated with long-COVID are:
▫ older age children
▫ female gender
▫ severe COVID-19
▫ overweight/obesity
▫ comorbid allergic diseases and other long-term co-morbidities

Click to enlarge


Conclusion

The authors of the systematic review and meta-analyses of Long-COVID in children and adolescents conclude:

🧾
Protective measures are essential to prevent long-COVID in children. We need to understand the long-COVID pathophysiology and symptomatology to support clinical management systems, establish rehabilitation programs, and design guidelines and therapeutic research.
Long-COVID represents a significant public health concern, and there are no guidelines to address its diagnosis and management.
“Our meta-analyses further support the importance of continuously monitoring the impact of long-COVID in children and adolescents and the need to include all variables and appropriate control cohorts in studies to better understand the real burden of pediatric long-COVID.”






additional data


Weekly New Hospital Admissions for COVID-19 (per million)




Total Cases & Total Deaths




Orphanhood in the UK

🕯️ Orphanhood of children from COVID-19 is estimated at 15,189 in the UK.
🚨 A tragedy never mentioned in the media.
(Source: Imperial College London)




Orphanhood in the World

🕯️ Globally 10.5M children lost parents or caregivers and 7.5M children experienced COVID-associated orphanhood.
(Source: JAMA Network)




Estimated ®️ Number

(Sources: UK Health Security Agency + Welsh Government
+ Scottish Government + N-I Ministry of Health)



Population Testing Positive for COVID-19

(Source: ONS)



Number of contact tracing alerts sent (England & Wales)

(Source: NHS)



Stringency Index

(Source: University of Oxford)






data sources


📚 Data Sources:



PMP Magazine



Going further:

  • Estimates of the population for the UK, England and Wales, Scotland and Northern Ireland, 2019 | ONS
  • Rugby, Warwickshire





  • — AUTHOR —


    J.N. PAQUET, Author & Journalist, Editor of PMP Magazine.



    Sources
    • Text: This piece was first published in PMP Magazine on 7 Sept 2022. | The authors write in a personal capacity.
    • Data cross-referenced with the latest official data from the UK dashboard.
    • Cover: Adobe Stock/SergeyBitos.
    • Icons from www.flaticon.com





    [Read our Comments Guidelines]